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Abstract
Background: Research on antimicrobial cationic peptides (AMPs) has gained pace toward using their potential to
replace conventional antibiotics. These peptides preferentially interact with negatively charged membrane lipids
typically seen in bacteria and thereby lead to membrane perturbations and membrane dysfunction. However, one
possible disadvantage of AMP drugs is their potential for toxicity, especially to those cells which display
externalization of negatively charged moieties to the outer leaflet of the plasma membrane during the process of
syncytialization. Human placental villous trophoblast is one such cell type. Indeed, intra-vaginal administration of an
antimicrobial cationic peptide Ala8,13,18-magainin II amide (AMA) which is a synthetic analogue of magainin 2
derived from Xenopus frog has been observed to result in inhibition of pregnancy establishment in monkeys.
However, only little is known about the cellular behavior of early placental cytotrophoblasts (CTB) in the presence
of cationic antimicrobial peptides. It is believed that suitable cell culture approaches using AMA as a representative
alpha-helical AMP may yield tangible knowledge in this regard.
Methods: Immunocytochemical (ICC) analyses using confocal microscopy (n = 6 for each treatment sub-group)
and Western blot (WB) method (n = 5 for each treatment sub-group) of CTB differentiation based on synthesis of
beta-hCG and hPL, and apoptosis based on apoptosis-associated cytokeratin 18 neo-epitope (CK18f) were
performed for CTB isolated from human first trimester placental villi and grown in serum-free primary culture for
24 h, 48 h and 96 h on rat-tail collagen with and without AMA (1000 ng/ml). Moreover, secretion of beta-hCG and
hPL into conditioned media from isolated CTB grown in vitro for 24 h, 48 h and 96 h (n = 6/each sub-group) with
and without AMA was examined using enzyme immunoassays. Furthermore, TUNEL assay, and cell viability based
on LDH leakage into medium (n = 6/each sub-group) were assessed to examine the phenomenon of cell death
with time and administration of AMA.
Results: CTB in serum-free primary culture showed increased (P < 0.05) level of synthesis and secretion of
beta-hCG and hPL with time, and higher (P < 0.05) level of cellular cytokeratin 18 neo-epitope and number of
TUNEL-positive cells, and LDH activity in conditioned medium at 96 h of culture. Exposure of CTB to AMA resulted
in lower (P < 0.05) level of synthesis and secretion of beta-hCG and hPL, as well as, an increase (P < 0.05) of
cellular cytokeratin 18 neo-epitope and number of TUNEL-positive cells, and LDH activity in conditioned medium
at 96 h as compared to the control treatment.
Conclusions: Administration of AMA resulted in attenuation of differentiation, enhancement in apoptosis and
loss of viability in early placental villi trophoblast cells in primary culture. Thus, it appears that administration of
alpha-helical AMP may adversely affect the process of placentation and pregnancy outcome.
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One major challenge of medicine today is the growing
number of bacterial strains resistant to conventional
antibiotic therapies. Hence, the need for new antibiotics
or even alternative compounds has stimulated research
in the field of antimicrobial peptides to be used as
human therapeutics [1,2]. To this effect, research on
gene-encoded cationic antimicrobial peptides (AMPs)
has gained pace in the recent time [3]. AMPs can be
defined as being short peptides (10-50 amino acids) with
an overall positive charge (+2 to +9) and a substantial
proportion of (>30%) of hydrophobic residues [3-5].
These chemical properties in AMPs generally result in
folds into amphiphilic structures, especially upon con-
tact with membranes and give rise to formation of sepa-
rate patches rich in positively charged and hydrophobic
amino acids [3-5]. There are four broad structural
groups of AMPs: a-helical peptides (for example, cercopin
B, magainins, LL37), extended structures rich in glycine,
proline, tryptophan, arginine, histidine (for example, indo-
licidin and histatin 1), peptides with one disulfide bond
(for example, bactenecin and esculentin A), and b-sheet
peptides stabilized by two or more disulfide bridges (for
example, human defensins and protegrins) [3-6]. These
peptides preferentially interact with negatively charged
lipids, which are major components of bacterial cell mem-
branes resulting in membrane perturbations such as pore
formation, alterations of the curvature strain and induction
of lipid-peptide domain formation [7]. Such perturbations
may alter the micro-environment of membrane proteins
resulting in membrane dysfunction. In mammalian cell
membranes however negatively charged lipids such as
phosphatidylserine are mostly located in the inner leaflet of
the membrane and thus are not exposed to the outer
surface of the cell. However, during pregnancy such pep-
tides may jeopardize placental villous trophoblasts because
these cells show externalization of negatively charged phos-
phatidylserine moieties to the outer leaflet of the plasma
membrane during the process of syncytialization [8]. This
may make them vulnerable to AMPs [9]. In fact, one pos-
sible disadvantage AMP drugs, especially for a-helical
AMPs, is their potential for toxicity [10], although the
issue of AMP drugs mediated toxicity on placental tro-
phoblasts has hitherto been little addressed [3].
Ala
8,13,18-magainin II amide (AMA) is a synthetic
AMP [11,12] belonging to a-helical peptide group of
AMPs and modified from natural magainin 2 obtained
from African frog Xenopus leavis [13,14]. Replacement
of three amino acid residues (Ser
8,G l y
13,G l y
18)o f
magainin 2 peptide with alanine enhances its antimicro-
bial activity, and amidation of its terminal amino acid
renders stabilization to its a-helical conformation [12].
It shows chemical properties that are very similar to
that of human a-helical AMP, cathelicidin peptide
LL-37 [3,6] and is commercially available. In a previous
study, we have reported that intra-vaginal administration
of AMA resulted in the inhibition of blastocyst implan-
tation in the rhesus monkey [9]. Further study in the
same species indicated that the anti-nidatory effect of
AMA might be resulted from its inhibitory effect on
trophoblast cell differentiation [15]. However, little is
known about the cellular behavior of early placental
t r o p h o b l a s tc e l l si nt h ep r e s e n c eo fc a t i o n i ca n t i m i c r o -
b i a lp e p t i d e s .I ti sa s s u m e dt h a ts u i t a b l ec e l lc u l t u r e
approaches using AMA as an AMP of non-defensins
group may yield tangible knowledge in this regard.
In the present study, we aimed to examine the in vitro
effects of AMA on cellular processes like differentiation
and apoptosis in primary human placental villous cytotro-
phoblasts (CTB) isolated from first trimester placental tis-
sues. To this end, we have employed well known markers
of cellular phenotype for trophoblast differentiation, apop-
tosis and viability in primary cell culture system [16].
Table 1 provides a summary of the target proteins exam-
ined in the present study. The assessment of CTB differen-
tiation in culture has been performed by examining
synthesis and secretion of human chorionic gonadotropin
beta (bhCG) and human placental lactogen (hPL) [16-18].
The assessment of apoptosis was done by examining the
level of caspase-mediated cleavage of cytokeratin 18 yield-
ing a specific neo-epitope (cytokeratin 18 neo-epitope,
CK18f), and nuclear DNA fragmentation using terminal
deoxynucleotidyl transferase (TdT) enzyme based TUNEL
(TdT dUTP nick end labeling) assay in trophoblast cells.
Both methods are based on well characterized phenomena
of apoptosis at cytoplasm and nucleus, respectively; these
are considered robust approaches in studying apoptosis
[19,20]. The loss of cell viability in culture with and with-
out AMA at different time points was assessed from lac-
tate dehydrogenase (LDH) activity in the conditioned
media. This approach is based on the fact that the loss of
intracellular LDH into the culture medium is a reliable
indicator of irreversible cell membrane damage and cell
death [21].
Methods
Tissue samples and chemicals
Human placental samples (N = 47) were obtained from
women (age: 23-37 years) undergoing elective surgical
termination of singleton pregnancy between 6 and 8
weeks of gestation (timed from last menstrual period)
without undergoing any prior medication. All women
provided their written informed consent. The Ethics
Committee of the All India Institute of Medical Sciences
approved the research study. The study also complied
with the Helsinki declaration. Placental samples were
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Page 2 of 10collected in sterile ice-cold phosphate buffered saline
(PBS, pH 7.4) and transported on ice to the laboratory
within 15 min after collection for further processing. All
the chemicals were obtained from Sigma Chemical Co.
(St. Louis, MO, USA), if not stated otherwise.
Isolation of placental villous trophoblast cells
CTB were isolated from freshly collected first trimester
placental villi as described previously [22-26]. Briefly,
villous tissues (2-3 g) were dissected from chorionic
membranes and washed with sterile cold Ca
2+/Mg
2+ free
PBS (pH 7.4) containing gentamycin (50 μg/ml) and
D-glucose (1 mg/ml). Placental tissues were incubated in
an enzyme mixture [0.25% (w/v) trypsin, 0.02% (w/v)
deoxyribonuclease type-I (DNase I), 15 mM HEPES,
5 mM magnesium sulphate, penicillin (100 IU/ml), strep-
tomycin (100 μg/ml) and amphotericin B (2.5 μg/ml)] at
37°C initially for 30 min and then for another three cycles
of 10 min each. Cell suspension was passed through a
pre-equilibrated mesh filter (pore size 60 μm) to remove
cellular debris. The filtrate was subjected to enrichment
on a preformed 10% to 70% Percoll gradient at 800 × g
for 20 min at 20°C. The mononuclear cells were immu-
nopurified by depletion of CD45-positive leucocytes
using MACS microbeads conjugated with monoclonal
mouse antibody against CD45 and magnetic separation
columns type LS in combination with a MidiMACS
separator (Miltenyi Biotec, Bergisch Gladbach, Germany)
[25]. The negative fraction containing an enriched villous
trophoblast cell population was collected and immuno-
characterized for cytokeratin 7, bhCG, CD51, von Will-
ebrand factor (vWF) and vimentin.
Cell culture
The methodological details of CTB culture have been
detailed previously [24-26]. Briefly, isolated mononucleated
CTB were plated at a density of 1 × 10
5/cm
2 on collagen
I and cultured at 37°C in a humidified air atmosphere of
5% CO2 and in complete medium [DMEM: F12 (1:1),
10% (v/v) fetal calf serum, penicillin (100 IU/ml), strepto-
mycin (100 μg/ml), amphotericin B (2.5 μg/ml)] for 24 h
to allow for their attachment to collagen. Subsequently,
the cells were maintained by daily feeding in serum-free
medium with antibiotics and antimycotics as described
above and supplemented with insulin (5 μg/ml), transfer-
rin (5 μg/ml), selenium (5 ng/ml) and hydrocortisone
(0.5 μg/ml) based on the initial optimization observation
that addition of these factors render more number of tar-
get cells attached, viable and aggregated in serum-free
primary culture on rat-tail collagen. It has also been
earlier reported that collagen and insulin supported CTB
differentiation in primary culture [27]. The same pools of
cells were treated with or without AMA (1000 ng/ml) in
triplicates to harvest at 24 h, 48 h and 96 h. The concen-
tration of AMA in the present study was selected based on
the previously reported dose finding study on viability,
hCG secretion and invasion efficiency for isolated CTB
indicating that AMA at 1000 ng/ml affected trophoblast
invasion into collagen coated membrane with 8 μm pores
without any marked effect on hCG secretion and mito-
chondrial viability at 48 h in presence of serum containing
medium [25]. In initial experiments, method optimization
for the methods employed in the present study was
performed at three time points as mentioned above in at
least three successive satisfactory experiments.
TUNEL assay
After termination of cultures at 24 h (n=6 ), 48 h (n=6 )
and 96 h (n=6 ) in triplicates, cells treated with and
without AMA (1000 ng/ml) were subjected to in situ
detection of nuclear fragmentation according to the
methods described elsewhere [28,29]. In brief, cells were
Table 1 Characteristics of targets and primary antibodies used in the study
Antigen Specification of
antibody
Final concentration Purpose*
b-actin Sheep IgG
a 2.0 μg/ml Internal normalization control, used in WB
Cytokeratin 7 Mouse IgG
b 6 μg/ml Epithelial cell marker, used in ICC
Cytokeratin 18 neo-epitope (CK18f) Mouse IgG
c 1:50 (WB); 1:20 (ICC) Early apoptosis marker, used in WB and ICC
bhCG Rabbit IgG
c 4 μg/ml (WB); 10 μg/ml
(ICC)
CTB differentiation marker, used in WB and ICC
hPL Goat IgG
d 3 μg/ml (WB); 7 μg/ml
(ICC)
CTB differentiation marker, used in WB and ICC
Vimentin Mouse IgG
a 3 μg/ml Cytoskeletal protein marker for fibroblasts, used in ICC
Vitronectin receptor, Integrin aVb3
(CD51)
Mouse IgG
e 10 μg/ml Invasive CTB marker, used in ICC
von Willebrand factor Rabbit IgG
c 25 μg/ml Endothelial cell marker (in Weibel-Palade bodies), used
in ICC
*see references [17-19,23-27,32] for details.
CTB, cytotrophoblast cells. ICC, immunocytochemistry. WB, Western blot analysis.
aR&D Systems, Minneapolis.
bSigma Chemical, St Louis, MO, USA.
cDako, Glostrup, Denmark.
dSanta Cruz Biotechnology, Santa Cruz, CA, USA.
eZymed
Laboratories, San Francisco, CA, USA.
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Page 3 of 10washed in phosphate buffer saline (PBS, pH 7.4), fixed in
4% (w/v) paraformaldehyde in PBS followed by permeabi-
lization, quenching and incorporation of labeled nucleo-
tides (BrdU) with TdT enzyme reaction onto free 3’OH
ends of DNA fragments and their detection with the help
of biotinylated anti-BrdU antibody using TACS-XL kit
obtained from Trevigen, Inc. (Gaithersburg, MD, USA).
Samples along with positive control with nuclease treat-
ment and negative control without enzyme were run as
per the method protocol provided by the supplier. The
labeled cells were counterstained with nuclear fast red
and cell numbers were estimated from nuclear counts.
All samples were analysed in one run.
Immunofluorescent staining and image analysis
After termination of culture at 24 h, 48 h, and 96 h,
cells treated with and without AMA (1000 ng/ml) were
subjected to immunocytochemical (ICC) staining using
various antibodies as described in Table 1. Immuno-
fluorescent staining was performed on six samples in
duplicates for each treatment group using a method
described earlier [30]. Appropriate fluorochrome-conju-
gated secondary antibodies (Molecular Probes, Grand
Island, NY, USA) were used for visualization. Specificity
of the antibody binding was assessed by omitting pri-
mary antibodies, immunoadsorption of primary antibo-
dies with target antigens, replacing primary antibodies
with unrelated IgG from same species and other species,
omitting secondary antibodies, and replacing secondary
antibodies with unrelated IgGs from same or other
species in parallel cultures.
Non-overlapping images (at least eight) from entire
area of confluence of each culture after ICC were exam-
ined using a Confocal laser scanning microscope (Leica
Microsystems, Wetzlar GmbH, Germany). The cells
were detected using an interactive planimeter analyzer
only in cases where discernibility was distinct. The
immunopositive cells were identified by detecting posi-
tive profiles in digitized images. Following image grab-
bing and segmentation, digitalized images were
subjected to image analysis for estimation of immuno-
positive area fraction (in per cent) based on manual out-
lining method and using an optimized grey level
threshold yielding normal distribution of image pixels
throughout the entire gray scale and shading correction.
Pixel calibration was done against the standard provided
by the manufacturer. The per cent immunostained areas
was measured using a precalibrated computer-assisted
digital image analysis system (Leica QWIN DC 200,
Cambridge, UK) as described elsewhere [30]. The nuclei
were counterstained with diamidino-6-phenylindole
(DAPI) (Molecular Probes), and cell numbers were esti-
mated from DAPI positive nuclear counts.
Immunoblots
After termination of cultures at 24 h (n=5 ), 48 h (n=
5)a n d9 6h( n=5 ) in duplicate with and without
AMA (1000 ng/ml), cells were subjected to Western
blot (WB) analysis. Profiles of the candidate proteins
in cell homogenates were assessed in samples of 25 μg
protein content along with pre-stained molecular
weight markers based on SDS-PAGE/Western immu-
noblotting method on nitrocellulose membrane using
electrophoresis and trans-blot equipment, and chemi-
cals obtained from Bio-Rad (Hercules, CA, USA) as
described elsewhere [30]. Final visualization was
achieved by using Vectastain ABC immunoperoxidase
kits (Vector Laboratories). Respective primary antibody
and secondary antibody controls were run simulta-
neously to examine the specificity of procedure. The
molecular weights and semi-quantitative densitometric
analysis of bands were determined using a densito-
metric equipment (Pharos FX Plus Molecular Imager,
Bio-Rad, Hercules, CA, USA) and an optimized densi-
tometric analysis software (PD Quest Advanced, Bio-
Rad). The integrated measures of optical densities for
individual antigens were calculated from log of trans-
mittance for each of the target antigen and normalized
with that of b-actin.
Analysis of bhCG, hPL and LDH in conditioned media
After termination of cultures at 24 h (n=6 ), 48 h (n=
6)a n d9 6h( n=6 ) in triplicates with and without
AMA (1000 ng/ml), supernatant from each cell culture
well was collected, centrifuged and stored at -80°C for
estimation of secreted bhCG and hPL by enzyme
immunoassays (25) and lactate dehydrogenase (LDH)
activity using standardized methods. The immunoassay
kits for bhCG and hPL were purchased from DRG
International Inc. (New Jersey, NJ, USA). The ranges
of detectable concentrations in the assays were 5 - 300
mIU/ml for bhCG and 1 - 20 mIU/ml for hPL. All
samples were analysed in one run. The intra-assay
coefficients of variation for both enzyme immunoas-
says were less than 9%.
The potential cytotoxic effect of AMA (1000 ng/ml) to
isolated CTB in culture with or without AMA at differ-
ent time points was assessed by lactate dehydrogenase
(LDH) leakage into the conditioned culture medium
using a LDH kit obtained from Sigma. The assay is
based on the conversion of lactate to pyruvate in the
presence of LDH with parallel reduction of NAD esti-
mated at 340 nm in a Benchmark Plus Spectrophot-
ometer (Bio-Rad, Hercules, CA, USA) with necessary
corrections [31]. All samples were analysed in one run.
The intra-assay coefficients of variation for both assays
were less than 6%.
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Page 4 of 10Statistical analysis
Statistical analysis of data was performed using Kruskal-
Wallis test followed by rank sums Wilcoxon test using
SPSS v17 (Chicago, IL, USA). The probability level of P
= 0.05 was taken as the limit of significance.
Results
The cell yield was ~3 × 10
6 cells/g wet weight of placen-
tal villous tissue with cell viability in trypan blue exclu-
sion method being more than 90%. These cells were
consistently positive for cytokeratin 7 (94 ± 3%) and
bhCG (93 ± 2%) and negative for vitronectin receptor
(CD51; 92 ± 3%), vimentin and von Willebrand factor
(99 ± 1%) in five cultures (Figure 1A-C).
Effect of time course
Isolated villous trophoblast cells grown on rat-tail type I
collagen in serum-free medium yielded adherent spher-
oid cells at 24 h (Figure 2A), showed aggregations at 48
h (Figure 2B), and formed distinct aggregates of fused
cells at 96 h (Figure 2C).
Immunocytochemical analyses revealed that isolated
primary villous cytokeratin 7- and bhCG-positive and
vitronectin receptor (CD51)-negative CTB in culture
synthesized an increasing amount of bhCG (P < 0.05)
and hPL (P < 0.05) at 48 h as compared to 24 h, and at
96 h as compared to 24 h and 48 h (Table 2; Figures
3A-C, G-I). A concomitant increase (P < 0.05) in con-
centrations of bhCG and hPL was also detected in the
conditioned media with time (Table 3). As shown in
Figure 4 and Table 2, immunoblot analysis of bhCG and
hPL protein expression after b-actin normalization in
cell homogenates however detected significant change
only at 96 h as compared to 24 h and 48 h with no
change observed between 24 h and 48 h.
Cytokeratin 18 neo-epitope level in cells and leakage
of LDH in media were higher (P < 0.05) at 96 h of cul-
ture as compared to 24 h and 48 h with no change
between 24 h and 48 h (Figures 3M-O, 4; Tables 2 and
3). The profiles of TUNEL assays also revealed a
detectable increase (P < 0.05) in the number of
TUNEL-positive cells at 96 h as compared to 24 h and
48 h, with no change observed between 24 h and 48 h
(Table 2).
Effect of AMA
Administration of AMA at a concentration of 1000 ng/
ml resulted in reduced numbers of cells and cell aggre-
gates (Figures 2D-F) along with a tendency of decreased
bhCG and hPL synthesis and secretion at each time
point, most markedly (P < 0.05) at 96 h (Figures 3D-F,
J-L, 4; Tables 2 and 3). Also, administration of AMA
resulted in increased amount of cytokeratin 18 neo-epi-
tope formation (Figures 3P-R, 4; Tables 2 and 3) and
the number of TUNEL-positive cells along with higher
degree of LDH leakage into the conditioned medium
with marked (P < 0.05) effect being observed at 96 h
(Table 3).
Figure 1 Immunocytochemical characterization of isolated villous trophoblast cells. Isolated cells were allowed to attach to the collagen
biomatrix and immunostained for cytokeratin 7 (CK7; A; green) and bhCG (B; green) and vitronectin receptor (CD51; C; green). Nuclei are
counterstained with DAPI (blue). Bar =4 0μm.
Figure 2 Representative microphotography of isolated villous
trophoblast cells grown on collagen biomatrix. Isolated cells
were allowed to attach to the collagen biomatrix and grow for 24 h
(A, D), 48 h (B, E) and 96 h (C, F) with 1000 ng/ml AMA (D, E, F) and
without AMA (A, B, C) in serum-free culture medium. Bar =2 0μm.
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In the present study we could obtain an enriched popu-
lation of cytokeratin 7 and bhCG positive and CD51
negative CTB from first trimester placental villi based
on a method of sequential enzymatic treatment and
plating the isolated cells on collagen I. It has been
demonstrated earlier that cytokeratin 7- and bhCG-posi-
tive and CD51 (vitronectin receptor)-negative CTB were
primarily villous in source, while cytokeratin 7-, bhCG-
and CD51-positive CTB were derived from extravillous
in source and invasive in nature [24,32]. Villous CTB in
the present primary culture model displayed functional
differentiation marked by increasing synthesis and secre-
tion of hCG and hPL over time. In the present study,
trophoblasts retained their biological functionality and
formed aggregates of fused cells in primary culture on
collagen [27]. However, we have not tested for syncytia-
lization using staining for membrane markers such as E-
cadherin or fodrin [33,34]; so we could not assess the
numbers of syncytia in our cultures.
Previously, several dynamic processes related to CTB
differentiation have been studied using primary cultures
of human placental villous trophoblast cells as a model
system [16,27,35]. It was earlier demonstrated that
mononucleated CTB isolated from placental villi by
trypsinization aggregated in a timed manner and fused
to form syncytiotrophoblast (STB) that synthesized and
secreted hCG and hPL [36,37]. Typically, CTB retrieved
from first trimester placental villi have been shown to
aggregate and start synthesizing hCG and hPL in culture
by 3-days [27,35]. Similar results were obtained in the
present study. A relatively high level of secretion of both
hormones by 48 h and more markedly at 96 h along
with marked degree of cell aggregration might be indi-
cative of positive influence of hCG on CTB differentia-
tion as well [38]. It is also apparent from the results of
the present study that a higher number of cells under-
went apoptosis and showed loss of viability as evident
from higher level of cytokeratin 18 neo-epitope in cells,
higher number of TUNEL-positive cells, and higher con-
centration of LDH leaked into the conditioned medium
at 96 h as compared to 24 h and 48 h cultures. It is gen-
erally believed that these three parameters relate well
with the apoptosis process and loss of cell viability [39].
The additional observation that the propidium iodide
positive cells showing binding to annexin V increased at
9 6ha sc o m p a r e dw i t ht h a ta t2 4ha n d4 8h( data not
shown) also substantiated the conclusion [40].
We also observed that exposure of villous CTB to the
cationic peptide AMA resulted in decreased production
and secretion of bhCG and hPL along with increased
degree cell apoptosis and loss of viability assessed from
cytokeratin 18 neo-epitope level and TUNEL-positive
nuclei containing cells, and LDH leakage into medium,
respectively. These actions of AMA collectively might
have resulted in observed pregnancy inhibition in mon-
keys [9,15].
The effect of AMA in attenuating the process of func-
tional differentiation in terms of bhCG and hPL synth-
esis and secretion and that on cell viability in primary
culture as observed in the present study should be con-
sidered against the background that villous trophoblasts
follow two tightly regulated pathways of differentiation
during placental development giving rise to differen-
tiated CTB in anchoring villi and floating villi. In the
anchoring villi, CTB aggregate into cell columns and
invade maternal decidua, while in the floating villi, CTB
differentiate into STB [41]. Thus, the present results
document that AMA inhibited only the pathway of CTB
differentiation into STB in vitro.
In a previous dose finding study, we observed that first
trimester human placental villous CTB maintained in
three dimensional culture subjected to AMA (1000 ng/
ml) treatment in the presence of serum (10%, v/v) did
Table 2 Effect of AMA on time course characteristics of
cellular behavior of placental villous CTB in vitro
Test parameter Median value (ranges)
Time
Treatment 24 h 48 h 96 h
Specific stain positivity in ICC (n = 6/each treatment sub-group)
bhCG
a
Control 13.0 (8-18) 17.5* (11-27) 23.5
(*)(18-32)
AMA 11.0 (9-20) 13.0 (9-22) 17.0 (11-24)
hPL
a
Control
1 9.5 (7-12) 5.5* (9-20) 21.0
(*)(14-30)
AMA 8.0 (6-13) 11.0 (8-18) 14.5 (10-21)
Cyto18 neo-epitope
a
Control 2.5 (1-4) 2.5 (1-5) 4.5
[*](3-8)
AMA 3.5 (2-6) 3.5 (2-7) 8.5
(*)(5-11)
TUNEL
b
Control 0 (0-3) 0 (0-2) 6
[*](3-9)
AMA 3 (0-5) 3 (1-7) 11
(*)(6-17)
Optical densityc in WB analysis (n = 5/each)
bhCG
Control 20.5 (11-27) 22.0 (12-28) 30.5
(*)(19-36)
AMA 18.0 (9-28) 21.5 (9-24) 22.5 (11-27)
hPL
Control 9.5 (6-12) 10.0 (7-18) 16.5
(*)
AMA 9.5 (7-13) 9.5 (6-18) 11.5 (9-21)
Cyto18 neo-epitope
Control 4.0 (2-5) 4.0 (2-6) 6.5
[*](3-11)
AMA 5.5 (2-7) 5.5 (2-8) 9.5
(*)(5-16)
apositive cellular area in per cent.
bnumber of positive cells in per cent.
cintegrated optical density normalized by that of b-actin per 25 μg of protein.
(*)P < 0.05 compared with any other group;
[*]P < 0.05 compared with 24 h
and 48 h groups in control treatment; *P < 0.05 compared with control
treatment at 96 h.
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Page 6 of 10Figure 3 Effect of time and magainin on immunopositive levels of bhCG, hPL and cytokeratin 18 neo-epitope (CK18f). Isolated villous
trophoblast cells grown on collagen biomatrix for 24 h (A, D, G, J, M, P), 48 h (B, E, H, K, N, Q) and 96 h (C, F, I, L, O, R) show immunopositive
staining for bhCG (A-F; green), hPL (G-L; red), and cytokeratin 18 neo-epitope (CK18f; M-R; green) treated with AMA (D-F, J-L, P-R) and without
AMA(A-C, G-I, M-O). The replacement of primary antibody with non-immune mouse IgG (S), non-immune rabbit and goat IgGs (T, U), as well as,
pre-neutralization of primary antibodies for bhCG (V) and (hPL) (W) with specific target antigens show no immunopositive staining. Nuclei are
counterstained with DAPI (blue). Bars =2 0μm.
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Page 7 of 10n o tr e s u l ti na n ys i g n i f i c a n tc h a n g ei nt h e i rm i t o c h o n -
drial viability and hCG secretion, however, with detect-
able reduction in invasion efficiency at 48 h as
compared to the control treatment (25). In the present
study, same concentration of AMA in serum-free med-
ium resulted in attenuation of differentiation, enhance-
ment in apoptosis and loss of viability in early placental
villi trophoblast cells at 96 h in vitro. Thus, it appears
that serum factors might render a potential protection
to cytotoxic action of AMA on early placental villous
CTB. The possibility that serum factors may provide
protection to mammalian cells from AMA mediated
cytotoxicity has also been indicated earlier by others
[3,42].
The underlying mechanism of the observed AMA
mediated intervention of trophoblast function in the
present study is not known, however, it appears that
two potential mechanisms may be examined in this
regard. Firstly, AMA might engage anionic domain in
the cell membrane of CTB during the process of syncy-
tialization and thereby resulted in functional inadequacy
and loss of viability as we proposed in the background
section based on previous reports [8,43]. It would
indeed be of interest to directly examine the involve-
ment of AMA with CTB cell membrane using high
resolution time lapse photomicrography with suitable
fluorochrome labels. The model used in the present
study however did not allow this type of investigation.
Secondly, AMA might act through calcium mediated
p r o c e s sa ss u g g e s t e di ns t u d i e so fm a g a i n i n2m e d i a t e d
histamine release [44] and caspase-independent apopto-
sis [45]. Indeed there is evidence to support that STB of
first trimester placenta express transient receptor poten-
tial (TRPC) homologues that are involved in store-oper-
ated calcium entry [46]. Therefore it will be interesting
to study calcium imaging in CTB treated with and with-
out AMA in vitro. In this context, it is notable that our
pilot experiments with isolated human endometrial stro-
mal cells grown on collagen biomatrix failed to
Table 3 Effect of AMA on time course characteristics of
levels of bhCG, hPL, and LDH activity in conditioned
medium of placental villous CTB in vitro
Test parameter Median value (ranges)
Time
Treatment 24 h 48 h 96 h
bhCG
a
Control 10.5 (9-14) 21.0
[*] (13-27) 40.5
(*) (26-55)
AMA 8.5 (6-11) 14.0 (9-19) 25.5<*> (11-33)
hPL
a
Control 8.5 (7-11) 13.5
[*] (7-17) 27.0
(*) (13-33)
AMA 9.0 (7-11) 9.5 (6-14) 15.5<*> (11-24)
LDH
b
Control 15.0 (11-20) 18.5 (13-26) 40.5
[*] (11-59)
AMA 18.0 (10-23) 22.0 (16-31) 64.5
(*) (46-87)
n=6 /each treatment sub-group.
ashown as mIU/ml/10
5 cells/d.
bLDH activity as IU/10
5 cells/d at 37°C.
(*)P < 0.05 compared with any other group;
[*]P < 0.05 compared with other
two sub-groups in control treatment group;
<*>P < 0.05 compared with other
two sub-groups in AMA treatment group.
Figure 4 Representative Western blot analysis of immunopositive levels of bhCG, hPL and cytokeratin 18 neo-epitope (CK18f) in
cytotrophoblast cells grown in primary culture. Cell lysates of isolated villous trophoblast cells grown on collagen biomatrix for 24 h, 48 h
and 96 h with or without AMA (1000 ng/ml) were electrophoretically separated and subjected to immunoblot analysis using b-actin as the
internal control.
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and viability following AMA administration, unlike iso-
lated CTB in vitro as observed in the present study.
Thus, it indicates that AMA mediated a specific effect
on the differentiation dynamics and viability of first tri-
mester placental villous CTB maintained in primary cul-
ture on collagen. Further experiments are needed to
investigate the anti-nidatory risk factors of AMP, vis-à-
vis, their potential application to combat reproductive
tract infection saving pregnancy based on new therapeu-
tic antibiotic approach [47]. It is interesting to note in
this context that AMA is an effective broad-spectrum,
non-specific antimicrobial agent that also inhibits
Herpes simplex virus types 1 and 2 also [2-6,48].
Conclusions
The antimicrobial cationic peptide AMA attenuates dif-
ferentiation and enhances apoptosis in primary villous
CTB isolated from first trimester placenta. Further stu-
dies to delineate the effect of AMA on early stage pla-
cental trophoblast cells may give important leads
towards understanding the anti-implantation risk factors
in new therapeutic antibiotic approaches.
Acknowledgements
The authors thank Dr. Manisha Kar and Mr. Harpal Singh for their support in
experiments and imaging operations, respectively. The authors also thank
Professor Peter Kaufmann for his critical comments and suggestions about
the experimental design and manuscript draft. The authors acknowledge the
support of the Confocal Imaging Facility of the Department of Physiology,
AIIMS. The study was supported by the Department of Science and
Technology, Government of India (Grant number D-209) and the
Department of Biotechnology, Government of India (Grant number N-915).
Author details
1Department of Physiology, All India Institute of Medical Sciences, New
Delhi, India.
2Institute of Cell Biology, Histology and Embryology, Medical
University Graz, Austria.
Authors’ contributions
JS, BH and DG contributed to the conception, designing, acquisition, analysis
and interpretation of data and the drafting process of the manuscript. MAK
contributed in performing experiments, data acquisition and analysis. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 August 2010 Accepted: 16 April 2011
Published: 16 April 2011
References
1. Gottler LM, Ramamoorthy A: Structure, membrane orientation,
mechanism, and function of pexiganan–a highly potent antimicrobial
peptide designed from magainin. Biochim Biophys Acta 2009,
1788:1680-1686.
2. Zaiou M: Multifunctional antimicrobial peptides: therapeutic targets in
several human diseases. J Mol Med 2007, 85:317-329.
3. Hancock REW, Sahl HG: Antimicrobial and host-defense peptides as new
anti-infective therapeutic strategies. Nature Biotechnol 2006, 24:1551-1557.
4. Zasloff M: Antimicrobial peptides of multicellular organisms. Nature 2002,
415:389-395.
5. Hancock REW, Lehrer R: Cationic peptides: a new source of antibiotics.
Trends Biotechnol 1998, 16:82-88.
6. Shai Y: From innate immunity to de-novo designed antimicrobial
peptides. Current Pharmaceut Design 2002, 8:715-725.
7. Matsuzaki K, Murase O, Fujii N, Miyajima K: An antimicrobial peptide,
magainin 2, induced rapid flip-flop of phospholipids coupled with pore
formation and peptide translocation. Biochemistry 1996, 35:11361-11368.
8. Huppertz B, Frank HG, Reister F, Kingdom JC, Korr H, Kaufmann P:
Apoptosis cascade progresses during turnover of human trophoblast:
analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab
Invest 1999, 79:1687-1702.
9. Dhawan L, Ghosh D, Lalitkumar PGL, Sharma DN, Lasley BL, Overstreet JW,
Sengupta J: Anti-nidatory effect of vaginally administered (Ala
8,1,18)-
magainin II amide in the rhesus monkey. Contraception 2000, 62:39-43.
10. Sandgren S, Wittrup A, Cheng F, Jonsson M, Eklund E, Busch S, Belting M:
The human antimicrobial peptide LL-37 transfers extracellular DNA
plasmid to the nuclear compartment of mammalian cells via lipid rafts
and proteoglycan-dependent endocytosis. J Biol Chem 2004,
279:17951-17956.
11. Zasloff M, Brian M, Chen HC: Antimicrobial activity of synthetic magainin
peptides and several analogues. Proc Natl Acad Sci (USA) 1988, 85:910-913.
12. Chen HC, Brown JH, Morell JL, Huang CM: Synthetic magainin analogues
with improved antimicrobial activity. FEBS Lett 1988, 236:462-466.
13. Zasloff M: Magainins, a class of antimicrobial peptides from Xenopus
skin: isolation, characterization of two active forms, and partial cDNA
sequence of a precursor. Proc Natl Acad Sci (USA) 1987, 84:5449-5453.
14. Bevins CL, Zasloff M: Peptides from frog skin. Ann Rev Biochem 1990,
59:395-414.
15. Ghosh D, Dhawan L, Lalitkumar PGL, Wong V, Rosario JF, Hendrickx AG,
Sengupta J: Effect of vaginally administered (Ala
8,13,18)-magainin II amide
on the morphology of implantation stage endometrium in the rhesus
monkey (Macaca mulatta). Contraception 2001, 63:335-342.
16. Ringler GE, Strauss JF III: In-vitro systems for the study of human
placental endocrine function. Endocr Rev 1990, 11:105-123.
17. Hoshina M, Hussa R, Pattillo R, Camel HM, Boime I: The role of trophoblast
differentiation in the control of the hCG and hPL genes. Adv Exp Med
Biol 1984, 176:299-312.
18. Kato Y, Braunstein GD: Purified first and third trimester placental
trophoblasts differ in in vitro hormone secretion. J Clin Endcrinol Metab
1990, 70:1187-1192.
19. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B,
Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H, Schutte B:
Immunocytochemical detection and mapping of a cytokeratin 8 neo-
epitope exposed during early apoptosis. J Pathol 1999, 187:567-572.
20. Negoescu A, Guillermet C, Lorimier P, Brambilla E, Labat-Moleur F:
Importance of DNA fragmentation in apoptosis with regard to TUNEL
specificity. Biomed Pharmacother 1998, 52:252-258.
21. Fotakis G, Timbrell JA: In-vitro cytotoxicity assays: Comparison of LDH,
neutral red, MTT and protein assay in hepatoma cell lines following
exposure to cadmium chloride. Toxicol Lett 2006, 160:171-177.
22. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III: Purification,
characterization, and in vitro differentiation of cytotrophoblasts from
human term placentae. Endocrinology 1986, 118:1567-1582.
23. Bischof P, Friedli E, Martelli M, Campana A: Expression of extracellular
matrix-degrading metalloproteinases by cultured human
cytotrophoblast cells: effects of cell adhesion and immunopurification.
Am J Obstet Gynecol 1991, 165:1791-1801.
24. Tarrade A, Lai Kuen R, Malassiné A, Tricottet V, Blain P, Vidaud M, Evain-
Brion D: Characterization of human villous and extravillous trophoblasts
isolated from first trimester placenta. Lab Invest 2001, 81:1199-1211.
25. Lamba P, Kar M, Sengupta J, Ghosh D: Effect of (Ala
8,13,18)-magainin II
amide on human trophoblast cells in vitro. Indian J Physiol Pharmacol
2005, 49:27-38.
26. Zhou WH, Du MR, Dong L, Yu J, Li DJ: Chemokine CXCL12 promotes the
cross-talk between trophoblasts and decidual stromal cells in human
first-trimester pregnancy. Hum Reprod 2008, 23:2669-2679.
27. Handwerger S, Aronow B: Dynamic changes in gene expression during
human trophoblast differentiation. Recent Prog Horm Res 2003, 58:263-281.
28. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell
death in situ via specific labeling of nuclear DNA fragmentation. J Cell
Biol 1992, 119:493-501.
Sengupta et al. Reproductive Biology and Endocrinology 2011, 9:49
http://www.rbej.com/content/9/1/49
Page 9 of 1029. Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C,
Brambilla C, Brambilla E: In situ apoptotic cell labeling by TUNEL method:
improvements and evaluation of cell preparation. J Histochem Cytochem
1996, 44:959-968.
30. Ghosh D, Najwa AR, Khan MA, Sengupta J: IGF2, IGF binding protein 1,
and matrix metalloproteinases-2 and -9 in implantation-stage
endometrium following immunoneutralization of vascular endothelial
growth factor in the rhesus monkey. Reproduction 2011, 141:501-509.
31. Lum G, Gambino SR: A comparison of serum versus heparinized plasma
for routine chemistry tests. Am J Clin Pathol 1974, 61:108-113.
32. Aboagye-Mathiesen G, Laugesen J, Zdravkovic M, Ebbesen P: Isolation and
characterization of human placental trophoblast subpopulations from
first-trimester chorionic villi. Clin Diagnost Lab Immunol 1996, 3:14-22.
33. Gauster M, Siwetz M, Orendi K, Moser G, Desoye G, Huppertz B: Caspases
rather than calpains mediate remodelling of the fodrin skeleton during
human placental trophoblast fusion. Cell Death Differ 2010, 17:336-345.
34. Aplin JD: Developmental cell biology of human villous trophoblast:
current research problems. Int J Dev Biol 2010, 54:323-329.
35. Aronow B, Richardson BD, Handwerger S: Microarray analysis of
trophoblast differentiation: gene expression reprogramming in key gene
function categories. Physiol Genomics 2001, 6:105-116.
36. Jeschke U, Richter DU, Walzel H, Bergemann C, Mylonas I, Sharma S, Keil C,
Briese V, Friese K: Stimulation of hCG and inhibition of hPL in isolated
human trophoblast cells in vitro by glycodelin A. Arch Gynecol Obstet
2003, 268:162-167.
37. Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Lauendeau I, Evain-
Brion D, Fournier T: Human chorionic gonadotropin expression in human
trophoblasts from early placenta: comparative study between villous
and extravillous trophoblastic cells. Placenta 2007, 28:175-184.
38. Shi QJ, Lei ZM, Rao CV, Lin J: Novel role of human chorionic
goandotropin in differentiation of human cytotrophoblasts. Endocrinology
1993, 132:1387-1395.
39. Johnson JE: Methods for studying cell death and viability in primary
neuronal cultures. Methods Cell Biol 1995, 46:243-276.
40. van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA,
Smits JFM, Daemen MJAP, Reutelingsperger CPM: Markers of apoptosis in
cardiovascular tissues: focus on Annexin V. Cardiovascul Res 2000,
45:549-559.
41. Knofler M: Critical growth factors and signaling pathways controlling
human trophoblast invasion. Int J Dev Biol 2010, 54:269-280.
42. McPhee JB, Scott MG, Hancock RE: Design of host defence peptides for
antimicrobial and immunity enhancing activities. Comb Chem High
Throughput Screen 2005, 8:257-272.
43. Huppertz B, Kingdom JC: Apoptosis in the trophoblast - role of apoptosis
in placental morphogenesis. J Soc Gynecol Investig 2004, 11:353-362.
44. Hook WA, Tsuji S, Siraganian RP: Magainin-2 releases histamine from rat
mast cells. Proc Soc Exp Biol Med 1990, 193:50-55.
45. Kulkarni MM, McMaster WR, Kamysz W, McGwire BS: Antimicrobial peptide-
induced apoptotic death of leishmania results from calcium-dependent
caspase-independent mitochondrial toxicity. J Biol Chem 2009,
284:15496-15504.
46. Clarson LH, Roberts VHJ, Hamark B, Elliot AC, Powell T: Store-operated Ca
2+
entry in first trimester and term human placenta. J Physiol 2003,
550.2:515-528.
47. Yedery RD, Reddy KV: Antimicrobial peptides as microbicidal
contraceptives: prophecies for prophylactics - a mini review. Eur J
Contracept Reprod Health Care 2005, 10:32-42.
48. Albiol Matanic VC, Castilla V: Antiviral activity of antimicrobial cationic
peptides against Junin virus and Herpes simplex virus. Int J Antimicrob
Agents 2004, 23:382-389.
doi:10.1186/1477-7827-9-49
Cite this article as: Sengupta et al.: In-vitro effects of the antimicrobial
peptide Ala8,13,18-magainin II amide on isolated human first trimester
villous trophoblast cells. Reproductive Biology and Endocrinology 2011 9:49.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sengupta et al. Reproductive Biology and Endocrinology 2011, 9:49
http://www.rbej.com/content/9/1/49
Page 10 of 10